Source link : https://newshealth.biz/health-news/mhra-approves-inavolisib-for-pik3ca-mutated-breast-cancer/
The MHRA has approved inavolisib for adults with PIK3CA-mutated HR+/HER2– breast cancer, offering a new targeted first-line therapy that significantly prolongs progression-free survival. Medscape News UK Source link : https://www.medscape.com/viewarticle/mhra-approves-inavolisib-pik3ca-mutated-breast-cancer-2025a1000x72?src=rss Author : Publish date : 2025-11-27 13:09:00 Copyright for syndicated content belongs to the linked Source.
The post MHRA Approves Inavolisib for PIK3CA-Mutated Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-27 13:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8